Seroquel Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder
Condition:   Depressive Disorder, Major Interventions:   Drug: Esketamine 28 mg;   Drug: Esketamine 56 mg;   Drug: Esketamine 84 mg;   Drug: Quetiapine XR 50 mg;   Drug: Quetiapine XR 100 mg;   Drug: Quetiapine XR 150 mg;   Drug: SSRI/SNRI Sponsor:   Janssen-Cilag International NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2020 Category: Research Source Type: clinical trials